TrialHuman vaccines & immunotherapeutics2017

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China.

Zhaojun Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.